RxDoctor Payments Data

Lisa Grunebaum, MD

Otolaryngology · Scottsdale, AZNPI 1003863093

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $74,193 of the $121,471 with a category attached, or 61.1%. AbbVie accounts for 74.7% of it on its own, with 9 other manufacturers making up the rest. Among otolaryngology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$121,471in general payments, 2019–2025

Across 175 payments — averaging $694.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$91K
  • Galderma Laboratories, L.p.$30K
  • Merz North America, Inc.$175
  • Revance Therapeutics, Inc.$143
  • Endo Pharmaceuticals Inc.$99
  • Galderma Research & Development, LLC$61
  • plus $103 from 4 others
$93,227in research payments, 2019–2025

Across 24 payments — averaging $3884.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$93K

What the payments were for

  • Consulting fees$74,19361%
  • Speaking & faculty fees$22,22018%
  • Travel & lodging$15,31713%
  • Food & beverage$9,7338%
  • Education$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$121,471 in reported general payments places this provider in the 95th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$57,514
Medicare patients
124
Services billed
697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →